MR and CT can be the key to explaining sudden hearing loss. Explanations are most commonly associated with a benign tumor of the acoustic nerve, commonly called an acoustic neuroma but more appropriately described as a vestibular schwannoma. But radiologists may have to look elsewhere to find the answer in patients with a genetic disorder called von Hippel-Lindau disease. Again, however, MR may hold the key.
MR and CT can be the key to explaining sudden hearing loss. Explanations are most commonly associated with a benign tumor of the acoustic nerve, commonly called an acoustic neuroma but more appropriately described as a vestibular schwannoma. But radiologists may have to look elsewhere to find the answer in patients with a genetic disorder called von Hippel-Lindau disease. Again, however, MR may hold the key.
Research scheduled to be published in the July 4 issue of Journal of the American Medical Association notes that hearing loss may occur due to hemorrhage in the inner ear caused by tumors in the endolymphatic sac or inner ear. These endolymphatic sac tumors (ELSTs) are associated with significant dysfunction of hearing and balance, including sudden irreversible hearing loss.
Dr. John A. Butman, a staff neuroradiologist at the National Institutes of Health Clinical Center, examined clinical findings and audiologic data on 35 patients with von Hippel-Lindau disease, finding ELSTs in 38 ears.
"ELSTs typically are very rare but common in patients with this disease," he said.
The study did not address the effectiveness of surgical resection. Butman found, however, that in several small operative series, complete resection of ELSTs can be curative, can alleviate vestibular symptomatology, and can be performed with hearing preservation and minimal morbidity.
Butman and colleagues concluded in the JAMA article that serial clinical evaluations and high-resolution MR and CT imaging to detect small ELSTs or intralabyrinthine hemorrhage are warranted in patients with this genetic disease.
When looking for the causes of hearing loss, Butman advises radiologists to look first for a vestibular schwannoma. In the absence of that, he said MR can uncover pathologies of the labyrinth itself, as well as abnormal enhancement in the cochlea or vestibule, which may indicate labyrinthitis or a neoplasm. MR and CT are also very good at finding morphological abnormalities in the cochlea and vestibule and in regions of the vestibular
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.